神经疾病中的类淋巴通路
类淋巴通路是2012年在啮齿动物脑内发现的液体清除通路,依赖AQP4将CSF沿动脉周围间隙导入脑实质,再经静脉周围和神经周围间隙清除溶质至脑膜和颈部淋巴管。啮齿动物中该通路主要在睡眠时活跃,Aβ清除较清醒时增加两倍;人类MRI和PET研究显示类似通路存在,睡眠剥夺后Aβ积聚,阿尔茨海默病患者CSF清除减少。
要点
- 类淋巴通路在啮齿动物睡眠时活跃,Aβ清除较清醒时增加两倍。
- 人类MRI显示CSF沿类似类淋巴通路的路径流动。
- 单夜睡眠剥夺后健康人脑内Aβ积聚,提示人类类淋巴通路可能主要在睡眠时活跃。
核心结论
- 啮齿动物和人类类淋巴及脑膜淋巴系统的特征需要重新评估CSF-间质液流动的解剖路径及其在CNS健康中的生理作用。
研究设计与样本
- 综述,总结啮齿动物和人类类淋巴通路及脑膜淋巴系统的研究进展。
主要发现
- 啮齿动物中类淋巴通路主要在睡眠时活跃,Aβ清除较清醒状态增加两倍。
- 人类MRI鞘内注射对比剂显示CSF沿类似啮齿动物类淋巴通路的路径流动。
- PET研究显示健康人单夜睡眠剥夺后Aβ积聚。
- 阿尔茨海默病患者CSF中Aβ和tau示踪剂清除较健康对照减少,且与灰质Aβ浓度增加相关。
- 阿尔茨海默病或正常压力脑积水患者脑组织AQP4表达改变;正常压力脑积水患者类淋巴MRI显示CSF示踪剂进入和清除减少。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要研究确认驱动啮齿动物类淋巴通路的特定因素是否也适用于人类。
- 需要纵向影像研究评估人类CSF动力学以确定脑溶质清除减少与神经退行性疾病发展之间是否存在因果联系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The glymphatic (glial-lymphatic) pathway is a fluid-clearance pathway identified in the rodent brain in 2012. This pathway subserves the flow of CSF into the brain along arterial perivascular spaces and subsequently into the brain interstitium, facilitated by aquaporin 4 (AQP4) water channels. The pathway then directs flow towards the venous perivascular and perineuronal spaces, ultimately clearing solutes from the neuropil into meningeal and cervical lymphatic drainage vessels. In rodents, the glymphatic pathway is predominantly active during sleep, when the clearance of harmful metabolites such as amyloid β (Aβ) increases two-fold relative to the waking state. Glymphatic dysfunction, probably related to perturbed AQP4 expression, has been shown in animal models of traumatic brain injury, Alzheimer's disease, and stroke. The recent characterisations of the glymphatic and meningeal lymphatic systems in rodents and in humans call for revaluation of the anatomical routes for CSF-interstitial fluid flow and the physiological role that these pathways play in CNS health. RECENT DEVELOPMENTS: Several features of the glymphatic and meningeal lymphatic systems have been shown to be present in humans. MRI scans with intrathecally administered contrast agent show that CSF flows along pathways that closely resemble the glymphatic system outlined in rodents. Furthermore, PET studies have revealed that Aβ accumulates in the healthy brain after a single night of sleep deprivation, suggesting that the human glymphatic pathway might also be primarily active during sleep. Other PET studies have shown that CSF clearance of Aβ and tau tracers is reduced in patients with Alzheimer's disease compared with healthy controls. The observed reduction in CSF clearance was associated with increasing grey-matter concentrations of Aβ in the human brain, consistent with findings in mice showing that decreased glymphatic function leads to Aβ accumulation. Altered AQP4 expression is also evident in brain tissue from patients with Alzheimer's disease or normal pressure hydrocephalus; glymphatic MRI scans of patients with normal pressure hydrocephalus show reduced CSF tracer entry and clearance. WHERE NEXT?: Research is needed to confirm whether specific factors driving glymphatic flow in rodents also apply to humans. Longitudinal imaging studies evaluating human CSF dynamics will determine whether a causal link exists between reduced brain solute clearance and the development of neurodegenerative diseases. Assessment of glymphatic function after stroke or traumatic brain injury could identify whether this function correlates with neurological recovery. New insights into how behaviour and genetics modify glymphatic function, and how this function decompensates in disease, should lead to the development of new preventive and diagnostic tools and novel therapeutic targets.
引用
- Rasmussen MK, Mestre H, Nedergaard M, et al. The glymphatic pathway in neurological disorders. Lancet Neurol. 2018. PMID: 30353860. doi:10.1016/S1474-4422(18)30318-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。